Supernus Pharmaceuticals, Inc.2024财年实现净利润73.87百万美元,同比增加5496.21%

市场透视
02 Mar

3月2日,Supernus Pharmaceuticals, Inc.(SUPN.US)公布财报,公告显示公司2024财年净利润为73.87百万美元,同比增加5496.21%;其中营业收入为6.62亿美元,同比增加8.88%,每股基本收益为1.34美元。从资产负债表来看,Supernus Pharmaceuticals, Inc.(SUPN.US)总负债4.65亿美元,其中短期债务6.89百万美元...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10